Olanzapine does not enhance cognition in non-agitated and non-psychotic patients with mild to moderate Alzheimer's dementia
- 1 November 2005
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 20 (11) , 1020-1027
Abstract
Objective This was an exploratory study of olanzapine as potential treatment for improvement in cognition in patients with Alzheimer's disease without prominent psychobehavioral symptoms. Methods Non‐psychotic/non‐agitated patients (n = 268) with Alzheimer's disease, who had baseline Mini‐Mental State Examination (MMSE) scores of 14–26 were randomized to treatment with olanzapine (2.5 to 7.5 mg/d) or placebo for 26 weeks. The primary objectives were to determine if treatment with olanzapine improved cognition as indexed by the Alzheimer's disease Assessment Scale for Cognition (ADAS‐Cog) and the Clinician's Interview‐Based Impression of Change (CIBIC) after 26 weeks of therapy. Results Patients treated with olanzapine vs placebo experienced significant worsening ADAS‐Cog scores at weeks 12 (p = 0.03) and 26 (p = 0.004). Changes in CIBIC scores were not significantly different between treatment groups at either assessment. A post hoc analysis revealed that olanzapine‐treated patients with more cognitive impairment at baseline (MMSE scores of 14–18) (n = 35) experienced significantly greater deterioration in ADAS‐Cog performance than patients in the placebo group (n = 24; p < 0.001); whereas in patients with less cognitive impairment (n = 78, baseline MMSE scores of 23–26) between‐group ADAS‐Cog changes were not significant. Conclusions In this 26‐week study non‐psychotic/non‐agitated patients with Alzheimer's disease treated with olanzapine experienced significant worsening of cognition as compared to placebo. Copyright © 2005 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's diseaseInternational Journal of Geriatric Psychiatry, 2004
- The spectrum of behavioral changes in Alzheimer's diseaseNeurology, 1996
- The Neuropsychiatric InventoryNeurology, 1994
- The Clinician Interview‐ Based Impression (CIBI)Neurology, 1994
- A Rating Scale for Drug-Induced AkathisiaThe British Journal of Psychiatry, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Self-rated sedation and plasma concentrations of desmethyldiazepam following single doses of clorazepatePsychopharmacology, 1979
- “Mini-mental state”Journal of Psychiatric Research, 1975
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970
- ALZHEIMERʼS DISEASEJournal of Nervous & Mental Disease, 1962